Canlyniadau Chwilio - Mustafa Celalettin Ugur

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endo... gan Nadia Harbeck, Peter A. Fasching, Rachel Wuerstlein, Tom Degenhardt, Diana Lüftner, Ronald Kates, Johannes Schumacher, P. D. Rath, Oliver Hoffmann, Ralf Lorenz, Thomas Decker, Mattea Reinisch, Thomas Göhler, Peter Staib, Oleg Gluz, Timo Schinköthe, Marcus Schmidt, Dirk Kieback, Marion Tina van Mackelenbergh, Carsten Hielscher, Mustafa Celalettin Ugur, Christoph Uleer, Mark‐Oliver Zahn, Ralf Meyer, Susanne Kraudelt, Andrea Stefek, Daniel Pink, Marianne Just, Hans‐Christian Kolberg, Tanja Fehm, Wolfram Malter, Mathias Warm, Helmut Forstbauer, Dirk Behringer, Anke Wortmann, Joachim Rom, Antje Lehnert, Sven Ackermann, Dagmar Guth, Eike Simon, Jan Dünnebacke, A Hönig, Peter Ehscheidt, K. Gnauert, Thorsten Kühn, Ekkehard von Abel, Andreas D. Hartkopf, Ulrich Karck, Martina Negwer, Jürgen Wacker, Manfred Welslau, J. Sagasser, Bernhard Heinrichm, Cosima Brucker, Heribert Stauder, Isolde Gröll, R. Felberbaum, Miloš A. Popović, Dirk-Toralf Baerens, Ulrike Söling, Matthias Zaiß, Jaqueline Rauh, Thomas Fietz, Jan Schröder, Hermann Voß, Johannes Mohm, Ute Neef, Lorenz Rieger, Andrea Distelrath, Arnd Nusch, B. Schmidt, Kerstin Lüdtke-Heckenkamp, Michael Berghorn, Steffi Busch, Caroline Schock, Michael Metz, Andreas Lorenz, Jens Uhlig, Burkhard Otremba

Cael y testun llawn Cael y testun llawn